[New method for the treatment of atrial fibrillation: circumferential cryoballoon ablation of the pulmonary vein]
- PMID: 18805763
- DOI: 10.1556/OH.2008.28454
[New method for the treatment of atrial fibrillation: circumferential cryoballoon ablation of the pulmonary vein]
Abstract
Atrial fibrillation is the most frequent arrhythmia with increasing prevalence. Given a limited success rate of drug therapy for atrial fibrillation, interventional treatment options have been developed during the last years. Catheter ablation of atrial fibrillation (until recently the mostly used energy source was radiofrequency energy) has been established as an important therapeutic alternative. Depending on interpersonal (both on patient and operator side) and technical variabilities using radiofrequency energy potentially life-threatening complications such as pulmonary vein stenosis or atrio-esophageal fistulas may occur. Cryoenergy is a novel energy source for transcatheter ablation eliminating the arrhythmia substrate by freezing. The cornerstone of catheter ablation for atrial fibrillation is electrical isolation of the pulmonary veins. During cryoballoon ablation the targeted pulmonary vein transiently occluded by the inflated balloon catheter and using this method a circumferential lesion is created. The success rate of cryoballoon ablation is comparable with the radiofrequency ablation with increased safety. We performed the first cryoballoon ablations for patients with paroxysmal atrial fibrillation in Hungary. On this occasion we review the potential advantages of this technique which may serve as basis for its widespread use in the future.
Similar articles
-
Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study.Europace. 2013 Nov;15(11):1567-73. doi: 10.1093/europace/eut104. Epub 2013 May 22. Europace. 2013. PMID: 23703361 Clinical Trial.
-
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.J Am Coll Cardiol. 2013 Apr 23;61(16):1713-23. doi: 10.1016/j.jacc.2012.11.064. Epub 2013 Mar 21. J Am Coll Cardiol. 2013. PMID: 23500312 Clinical Trial.
-
Rationale and design of the FreezeAF trial: a randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon catheter versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation.Am Heart J. 2010 Apr;159(4):555-560.e1. doi: 10.1016/j.ahj.2010.01.008. Am Heart J. 2010. PMID: 20362712 Clinical Trial.
-
Major complications of cryoballoon catheter ablation for atrial fibrillation and their management.Expert Rev Cardiovasc Ther. 2014 Sep;12(9):1111-8. doi: 10.1586/14779072.2014.925802. Epub 2014 Aug 12. Expert Rev Cardiovasc Ther. 2014. PMID: 25115140 Review.
-
Cryoballoon ablation in atrial fibrillation: Advantages and drawbacks.Rev Port Cardiol. 2017 Nov;36 Suppl 1:19-24. doi: 10.1016/j.repc.2017.09.008. Epub 2017 Nov 4. Rev Port Cardiol. 2017. PMID: 29108897 Review. English, Portuguese.
Cited by
-
Could successful cryoballoon ablation of paroxysmal atrial fibrillation prevent progressive left atrial remodeling?Cardiovasc Ultrasound. 2012 Mar 19;10:11. doi: 10.1186/1476-7120-10-11. Cardiovasc Ultrasound. 2012. PMID: 22429696 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical